Cat.#: ACPP-1189
| Despition | PDE6C Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1375 | Human GABARAPL1 Protein (AC1375) | 5 µg | inquiry |
| ACPP-1090 | PAX5 Blocking Peptide (AC1090) | 250 µg | inquiry |
| ACPP-1840 | Human ALDH1A1 Protein (AC1840) | 5 µg | inquiry |
| ACPP-1847 | Human GFRA3 Protein (AC1847) | 5 µg | inquiry |
| ACPP-1296 | Human FGF 19 Protein (AC1296) | 5 µg | inquiry |
| ACPP-1241 | Dopamine Receptor D4 Blocking Peptide (AC1241) | 250 µg | inquiry |
| ACPP-1611 | Human ICA69 Protein (AC1611) | 100 µg | inquiry |
| ACPP-1264 | SorLA Blocking Peptide (AC1264) | 250 µg | inquiry |
| ACPP-1382 | Human EYA2 Protein (AC1382) | 2 µg | inquiry |
| ACPP-1790 | Rat MANF Protein (AC1790) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.